Page last updated: 2024-08-21

indazoles and Kaposi Sarcoma

indazoles has been researched along with Kaposi Sarcoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cooper, A; De Souza, P; Harris, BHL; Manders, P; Neciunaite, R; Walsh, JL1

Other Studies

1 other study(ies) available for indazoles and Kaposi Sarcoma

ArticleYear
Ring a ring o'roses, a patient with Kaposi's? Pazopanib, pazopanib, it might go away. Mediterranean (classic) Kaposi sarcoma responds to the tyrosine kinase inhibitor pazopanib after multiple lines of standard therapy.
    Clinical and experimental dermatology, 2018, Volume: 43, Issue:2

    Topics: Aged, 80 and over; Humans; Indazoles; Male; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Sarcoma, Kaposi; Sulfonamides; Treatment Outcome

2018